Members of the 25th Navajo Nation Council and the Diné Uranium Remediation Advisory Commission (DURAC) met recently at the ...

Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...

Xaira Therapeutics today announced the appointment of Ian McCaffery, Ph.D., as Senior Vice President, Translational Science and Early Clinical Development, and the promotions of Ci Chu, Ph.D., to ...

Executive Director, Vita S. Salsman Immunocine Cancer Center She began her career in cellular immunotherapy at Baylor College of Medicine’s Center for Cell and Gene Therapy and Texas Children’s ...

Scientists have long relied on chemical traces locked inside ancient rocks to piece together the story of early life. Fossils ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

Bryan Johnson, the tech bro who is obsessed with becoming immortal, has revealed he has an incurable disease. Johnson has spent millions of dollars on treatments designed to extend his life, ...

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

As America celebrates its 250th birthday, it’s worth pausing to recognize one of our nation’s greatest achievements: a legacy ...

Seth Klarman is the CEO and portfolio manager of The Baupost Group. Baupost is an investment manager based in Boston, from ...

US FDA approves Orca Bio’s Tregzi for allogeneic transplant in adults with haematological malignancies: Menlo Park, California Thursday, July 2, 2026, 17:00 Hrs [IST] Orca Bio, ...